Optimized Near-IR Fluorescent Agents for in Vivo Imaging of Btk Expression

被引:49
作者
Kim, Eunha [1 ]
Yang, Katherine S. [1 ]
Kohler, Rainer H. [1 ]
Dubach, John M. [1 ]
Mikula, Hannes [1 ]
Weissleder, Ralph [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Ctr Syst Biol, 185 Cambridge St,CPZN 5206, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
BRUTONS-TYROSINE-KINASE; TARGETING BTK; SI-RHODAMINE; LIVE-CELL; IBRUTINIB; INHIBITOR; MACROPHAGES; ACTIVATION; PCI-32765; POTENT;
D O I
10.1021/acs.bioconjchem.5b00152
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Bruton's tyrosine kinase (Btk) is intricately involved in anti-apoptotic signaling pathways in cancer and in regulating innate immune response. A number of Btk inhibitors are in development for use in treating B-cell malignancies and certain immunologic diseases. To develop robust companion imaging diagnostics for in vivo use, we set out to explore the effects of red wavelength fluorochrome modifications of two highly potent irreversible Btk inhibitors, Ibrutinib and AVL-292. Surprisingly, we found that subtle chemical differences in the fluorochrome had considerable effects on target localization. Based on iterative designs, we developed a single optimized version with superb in vivo imaging characteristics enabling single cell Btk imaging in vivo. This agent (Ibrutinib-SiR-COOH) is expected to be a valuable chemical tool in deciphering Btk biology in cancer and host cells in vivo.
引用
收藏
页码:1513 / 1518
页数:6
相关论文
共 35 条
[1]   Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies [J].
Advani, Ranjana H. ;
Buggy, Joseph J. ;
Sharman, Jeff P. ;
Smith, Sonali M. ;
Boyd, Thomas E. ;
Grant, Barbara ;
Kolibaba, Kathryn S. ;
Furman, Richard R. ;
Rodriguez, Sara ;
Chang, Betty Y. ;
Sukbuntherng, Juthamas ;
Izumi, Raquel ;
Hamdy, Ahmed ;
Hedrick, Eric ;
Fowler, Nathan H. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (01) :88-94
[2]   Quantitative Immunofluorescence Reveals the Signature of Active B-cell Receptor Signaling in Diffuse Large B-cell Lymphoma [J].
Bogusz, Agata M. ;
Baxter, Richard H. G. ;
Currie, Treeve ;
Sinha, Papiya ;
Sohani, Aliyah R. ;
Kutok, Jeffery L. ;
Rodig, Scott J. .
CLINICAL CANCER RESEARCH, 2012, 18 (22) :6122-6135
[3]   Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia [J].
Byrd, John C. ;
Furman, Richard R. ;
Coutre, Steven E. ;
Flinn, Ian W. ;
Burger, Jan A. ;
Blum, Kristie A. ;
Grant, Barbara ;
Sharman, Jeff P. ;
Coleman, Morton ;
Wierda, William G. ;
Jones, Jeffrey A. ;
Zhao, Weiqiang ;
Heerema, Nyla A. ;
Johnson, Amy J. ;
Sukbuntherng, Juthamas ;
Chang, Betty Y. ;
Clow, Fong ;
Hedrick, Eric ;
Buggy, Joseph J. ;
James, Danelle F. ;
O'Brien, Susan .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (01) :32-42
[4]   Synthesis and In Vivo Fate of Zwitterionic Near-Infrared Fluorophores [J].
Choi, Hak Soo ;
Nasr, Khaled ;
Alyabyev, Sergey ;
Feith, Dina ;
Lee, Jeong Heon ;
Kim, Soon Hee ;
Ashitate, Yoshitomo ;
Hyun, Hoon ;
Patonay, Gabor ;
Strekowski, Lucjan ;
Henary, Maged ;
Frangioni, John V. .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2011, 50 (28) :6258-6263
[5]   Bruton tyrosine kinase is commonly overexpressed in mantle cell lymphoma and its attenuation by Ibrutinib induces apoptosis [J].
Cinar, Munevver ;
Hamedani, FaridSaei ;
Mo, Zhicheng ;
Cinar, Bekir ;
Amin, Hesham M. ;
Alkan, Serhan .
LEUKEMIA RESEARCH, 2013, 37 (10) :1271-1277
[6]  
DEWEERS M, 1994, J BIOL CHEM, V269, P23857
[7]   Inhibition of Btk with CC-292 Provides Early Pharmacodynamic Assessment of Activity in Mice and Humans [J].
Evans, Erica K. ;
Tester, Richland ;
Aslanian, Sharon ;
Karp, Russell ;
Sheets, Michael ;
Labenski, Matthew T. ;
Witowski, Steven R. ;
Lounsbury, Heather ;
Chaturvedi, Prasoon ;
Mazdiyasni, Hormoz ;
Zhu, Zhendong ;
Nacht, Mariana ;
Freed, Martin I. ;
Petter, Russell C. ;
Dubrovskiy, Alex ;
Singh, Juswinder ;
Westlin, William F. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2013, 346 (02) :219-228
[8]   Macrophages eat cancer cells using their own calreticulin as a guide: Roles of TLR and Btk [J].
Feng, Mingye ;
Chen, James Y. ;
Weissman-Tsukamoto, Rachel ;
Volkmer, Jens-Peter ;
Ho, Po Yi ;
McKenna, Kelly M. ;
Cheshier, Samuel ;
Zhang, Michael ;
Guo, Nan ;
Gip, Phung ;
Mitra, Siddhartha S. ;
Weissman, Irving L. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (07) :2145-2150
[9]   RETRACTED: MyD88 adapter-like (Mal) is phosphorylated by Bruton's tyrosine kinase during TLR2 and TLR4 signal transduction (Retracted Article) [J].
Gray, P ;
Dunne, A ;
Brikos, C ;
Jefferies, CA ;
Doyle, SL ;
O'Neill, LAJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (15) :10489-10495
[10]  
Grimm JB, 2015, NAT METHODS, V12, P244, DOI [10.1038/NMETH.3256, 10.1038/nmeth.3256]